Brad Urquhart, PhD (London, Ontario) – President
Brad Urquhart is Associate Professor in the Department of Physiology and Pharmacology and Associate Dean, Basic Medical Sciences Undergraduate Education at Western University. Brad has previously served on the CSPT scientific program committee and is currently the treasurer of CSPT. His research investigates mechanisms for variability in drug response and toxicity in kidney disease.
Dylan Burger, PhD (Ottawa, Ontario) - President-elect
Dylan Burger (PhD, ISHF) is a Senior Scientist at the Ottawa Hospital Research Institute and Associate Professor at the University of Ottawa (Department of Cellular and Molecular Medicine). His research focuses on understanding the molecular underpinnings of diabetes and hypertension and their associated cardiovascular complications. In particularly he has been active in the study of extracellular vesicles as markers and mediators of vascular and renal injury for more than 10 years. He has authored more than 110 manuscripts and has received several awards including the 2016 Canadian Society of Nephrology New Investigator Lectureship and the 2018 University of Ottawa Department of Medicine PhD Scientist Award. He is the former Chair of Communications for the International Society of Hypertension. Dr. Burger is a founding member of The Lancet Commission on Hypertension and Associate Editor for the European Heart Journal and the Journal of Extracellular Vesicles.
Donald Miller, PhD (Winnipeg, Manitoba) - Treasurer
Don Miller is a Professor in the Department of Pharmacology and Therapeutics and Principal Investigator in the Kleysen Institute for Advanced Medicine at the University of Manitoba. Don is a member of the scientific programming and outreach committees. His research focuses on blood-brain barrier transport and drug permeability and on improving therapeutic outcomes for various neurological disorders.
Canadian Society of Pharmacology and Therapeutics (CSPT) Copyright© 2024 CSPT. All rights reserved. Let's connect: Email | X(Twitter) | Facebook | LinkedIn |